Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $934,850 - $1.03 Million
-13,042 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $10.4 Million - $11.5 Million
-148,444 Reduced 91.92%
13,042 $1.01 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $7.53 Million - $8.87 Million
-109,336 Reduced 40.37%
161,486 $12.4 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $19.4 Million - $21.6 Million
270,822 New
270,822 $22.2 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $30.6 Million - $34 Million
-426,562 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $12.3 Million - $13.9 Million
167,989 Added 64.97%
426,562 $35.4 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $5.03 Million - $5.72 Million
-71,421 Reduced 21.64%
258,573 $20 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $9.42 Million - $13.1 Million
148,709 Added 82.03%
329,994 $25.4 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $7.1 Million - $8.01 Million
91,513 Added 101.94%
181,285 $16.5 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $562,535 - $613,184
-7,394 Reduced 7.61%
89,772 $7.21 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $26.4 Million - $30.8 Million
-377,850 Reduced 79.54%
97,166 $8.15 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $43.2 Million - $49.2 Million
-620,366 Reduced 56.63%
475,016 $39.5 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $67.3 Million - $78.1 Million
1,031,502 Added 1614.75%
1,095,382 $83.7 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $820,964 - $980,322
15,904 Added 33.15%
63,880 $3.6 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $2.81 Million - $3.03 Million
47,976
47,976 $3.07 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.